CLS Outpaces Industry in the Past 3 Months: Reason to Buy the Stock? (Revised)

Celestica (CLS) has outperformed its industry peers, gaining 24.3% in the last three months driven by demand for its AI and machine learning compute and networking products; earnings estimates for 2025 and 2026 have increased 5.7% and 2.4% respectively. While Celestica faces margin pressure from high R&D costs and macroeconomic uncertainty, particularly regarding trade policy, the company is positioned for long-term growth due to its technological expertise and infrastructure investments.

Analysis

Celestica Inc. (CLS) has demonstrated significant market outperformance, with its stock appreciating 24.3% over the past three months, exceeding the industry's 15.4% growth and surpassing peers Flex Ltd. (17.3% gain) and Jabil Inc. (14.7% gain). This performance is primarily fueled by strong demand within the generative AI (GenAI) sector, where Celestica provides critical high-speed 800G network switches and scalable AI storage platforms like the SC6100 controller and SD6200, positioning it as a key enabler for hyperscale customers. Reinforcing this positive momentum, earnings estimates for 2025 have risen by 5.7% to $5.05 and for 2026 by 2.4% to $6.07 in the past 60 days, reflecting bullish analyst sentiment. However, Celestica faces persistent margin pressures due to high research and development costs inherent in its advanced technology offerings, coupled with intense competition from industry giants. The company also remains cautious about the dynamic macroeconomic environment, particularly trade policy uncertainties, although recent temporary U.S. government exemptions for key data center IT hardware offer some near-term clarity for its Connectivity & Cloud Solutions (CCS) segment. Despite these headwinds, Celestica's robust infrastructure investments and technological expertise suggest long-term growth potential, though the current Zacks Rank #3 (Hold) indicates a need for investor caution amidst ongoing market volatility and operational challenges.

Key Decisions for Investors

• Investors should recognize Celestica's significant leverage to the GenAI boom, as evidenced by its recent 24.3% stock gain and upward earnings estimate revisions for 2025 and 2026.
• It is crucial to monitor the company's ability to manage margin compression from high R&D expenses and intense industry competition, alongside navigating macroeconomic uncertainties, particularly evolving trade policies impacting its CCS segment.
• Given the Zacks Rank #3 (Hold) and the article's cautious tone despite long-term optimism, a balanced approach is advisable, potentially holding existing positions while vigilantly tracking margin performance and trade developments before considering new or increased exposure.